Globus Medical Long Term Debt 2010-2024 | GMED
- Globus Medical long term debt for the quarter ending June 30, 2024 was $M, a NAN% increase year-over-year.
- Globus Medical long term debt for 2023 was $0.417B, a INF% increase from 2022.
- Globus Medical long term debt for 2022 was $0B, a NAN% decline from 2021.
- Globus Medical long term debt for 2021 was $0B, a NAN% decline from 2020.
Globus Medical Annual Long Term Debt (Millions of US $) |
|
---|---|
2023 | $417 |
2022 | $ |
2021 | $ |
2020 | $ |
2019 | $ |
2018 | $ |
2017 | $ |
2016 | $ |
2015 | $ |
2014 | $ |
2013 | $ |
2012 | $ |
2011 | $ |
2010 | $ |
2009 | $ |
Globus Medical Quarterly Long Term Debt (Millions of US $) |
|
---|---|
2024-06-30 | |
2024-03-31 | |
2023-12-31 | $417 |
2023-09-30 | $410 |
2023-06-30 | |
2023-03-31 | |
2022-12-31 | |
2022-09-30 | |
2022-06-30 | |
2022-03-31 | |
2021-12-31 | |
2021-09-30 | |
2021-06-30 | |
2021-03-31 | |
2020-12-31 | |
2020-09-30 | |
2020-06-30 | |
2020-03-31 | |
2019-12-31 | |
2019-09-30 | |
2019-06-30 | |
2019-03-31 | |
2018-12-31 | |
2018-09-30 | |
2018-06-30 | |
2018-03-31 | |
2017-12-31 | |
2017-09-30 | |
2017-06-30 | |
2017-03-31 | |
2016-12-31 | |
2016-09-30 | |
2016-06-30 | |
2016-03-31 | |
2015-12-31 | |
2015-09-30 | |
2015-06-30 | |
2015-03-31 | |
2014-12-31 | |
2014-09-30 | |
2014-06-30 | |
2014-03-31 | |
2013-12-31 | |
2013-09-30 | |
2013-06-30 | |
2013-03-31 | |
2012-12-31 | |
2012-09-30 | |
2012-06-30 | |
2012-03-31 | |
2011-12-31 | |
2011-09-30 | |
2011-06-30 | |
2011-03-31 | |
2010-12-31 | |
2009-12-31 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Instruments Manufacturing | $10.139B | $1.568B |
Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions for patients with musculoskeletal disorders. The company currently has its sales operations distributed across counties world wide. Its Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and unique surgical instruments, used in an expansive range of spinal, orthopedic and neurosurgical procedures. The spine products address the vast majority of conditions affecting the spine including degenerative conditions, deformity, tumors and trauma. Enabling Technologies are designed to enhance a surgeon's capabilities and streamline the complicated surgical procedures to be safer, less invasive, accurate and more reproducible to improve patient care and reduce radiation exposure for both patient and caregiver. The technology contains imaging, navigation and robotic assisted surgery solutions. It acquired all assets of StelKast, Inc. and Finnish engineering company Synoste Oy. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Thermo Fisher Scientific (TMO) | United States | $225.969B | 27.09 |
Intuitive Surgical (ISRG) | United States | $169.358B | 95.89 |
Alcon (ALC) | Switzerland | $47.001B | 33.09 |
IQVIA Holdings (IQV) | United States | $42.487B | 24.08 |
Edwards Lifesciences (EW) | United States | $41.144B | 26.37 |
IDEXX Laboratories (IDXX) | United States | $38.181B | 45.93 |
DexCom (DXCM) | United States | $28.011B | 39.94 |
STERIS (STE) | Ireland | $22.286B | 26.01 |
SONOVA HOLDING (SONVY) | Switzerland | $21.936B | 0.00 |
Waters (WAT) | United States | $21.012B | 31.33 |
Hologic (HOLX) | United States | $19.032B | 20.69 |
Sysmex ADR (SSMXY) | Japan | $11.883B | 37.26 |
Fresenius Medical Care AG KGaA (FMS) | Germany | $11.754B | 13.18 |
Teleflex (TFX) | United States | $11.078B | 17.23 |
Penumbra (PEN) | United States | $7.980B | 82.83 |
Masimo (MASI) | United States | $7.690B | 41.19 |
Glaukos (GKOS) | United States | $7.045B | 0.00 |
Integer Holdings (ITGR) | United States | $4.395B | 25.70 |
TransMedics (TMDX) | United States | $4.336B | 185.67 |
PROCEPT BioRobotics (PRCT) | United States | $3.763B | 0.00 |
LivaNova (LIVN) | United Kingdom | $2.888B | 16.94 |
Nihon Kohden (NHNKY) | Japan | $2.746B | 17.08 |
Veracyte (VCYT) | United States | $2.667B | 165.33 |
Elekta AB (EKTAY) | Sweden | $2.589B | 21.09 |
Inari Medical (NARI) | United States | $2.587B | 0.00 |
Tandem Diabetes Care (TNDM) | United States | $2.455B | 0.00 |
RxSight (RXST) | United States | $1.874B | 0.00 |
Integra LifeSciences Holdings (IART) | United States | $1.536B | 7.00 |
Artivion (AORT) | United States | $1.127B | 103.42 |
Pulse Biosciences (PLSE) | United States | $1.066B | 0.00 |
AVANOS MEDICAL, INC (AVNS) | United States | $1.053B | 18.79 |
OPKO Health (OPK) | United States | $1.039B | 0.00 |
Alphatec Holdings (ATEC) | United States | $0.808B | 0.00 |
Mesa Laboratories (MLAB) | United States | $0.723B | 18.26 |
OrthoPediatrics (KIDS) | United States | $0.672B | 0.00 |
IRadimed (IRMD) | United States | $0.653B | 35.31 |
AxoGen (AXGN) | United States | $0.634B | 0.00 |
ORTHOFIX MEDICAL INC (OFIX) | United States | $0.612B | 0.00 |
Pacific Biosciences Of California (PACB) | United States | $0.561B | 0.00 |
SiBone (SIBN) | United States | $0.551B | 0.00 |
Paragon 28 (FNA) | United States | $0.487B | 0.00 |
Tactile Systems Technology (TCMD) | United States | $0.342B | 10.42 |
Treace Medical Concepts (TMCI) | United States | $0.334B | 0.00 |
ClearPoint Neuro (CLPT) | United States | $0.331B | 0.00 |
Sight Sciences (SGHT) | United States | $0.303B | 0.00 |
Delcath Systems (DCTH) | United States | $0.264B | 0.00 |
AngioDynamics (ANGO) | United States | $0.253B | 0.00 |
Inogen (INGN) | United States | $0.222B | 0.00 |
Accuray (ARAY) | United States | $0.191B | 0.00 |
Nevro (NVRO) | United States | $0.189B | 0.00 |
NeuroPace (NPCE) | United States | $0.188B | 0.00 |
Semler Scientific (SMLR) | United States | $0.188B | 13.15 |
Atossa Genetics (ATOS) | United States | $0.185B | 0.00 |
CVRx (CVRX) | United States | $0.182B | 0.00 |
Alpha Tau Medical (DRTS) | Israel | $0.159B | 0.00 |
908 Devices (MASS) | United States | $0.122B | 0.00 |
KORU Medical Systems (KRMD) | United States | $0.122B | 0.00 |
Spectral Diagnostics (EDTXF) | Canada | $0.118B | 0.00 |
Sensus Healthcare (SRTS) | United States | $0.112B | 16.63 |
EDAP TMS S.A (EDAP) | France | $0.101B | 0.00 |
WORK Medical Technology Group (WOK) | China | $0.094B | 0.00 |
Monogram Orthopaedics (MGRM) | United States | $0.076B | 0.00 |
Hyperfine (HYPR) | United States | $0.073B | 0.00 |
Covalon Technologies (CVALF) | Canada | $0.067B | 0.00 |
LENSAR (LNSR) | United States | $0.065B | 0.00 |
InspireMD (NSPR) | Israel | $0.062B | 0.00 |
Envoy Medical (COCH) | United States | $0.053B | 0.00 |
Vicarious Surgical (RBOT) | United States | $0.048B | 0.00 |
EnVVeno Medical (NVNO) | United States | $0.045B | 0.00 |
Accelerate Diagnostics (AXDX) | United States | $0.045B | 0.00 |
Lucid Diagnostics (LUCD) | United States | $0.044B | 0.00 |
Adagio Medical Holdings (ADGM) | United States | $0.038B | 0.00 |
Rapid Micro Biosystems (RPID) | United States | $0.037B | 0.00 |
DarioHealth (DRIO) | United States | $0.031B | 0.00 |
Neuronetics (STIM) | United States | $0.028B | 0.00 |
Precision Optics (POCI) | United States | $0.028B | 0.00 |
Pixie Dust Technologies (PXDT) | Japan | $0.025B | 0.00 |
T2 Biosystems (TTOO) | United States | $0.024B | 0.00 |
Spectral AI (MDAI) | United States | $0.023B | 0.00 |
Baird Medical Investment Holdings (BDMD) | $0.021B | 0.00 | |
Ekso Bionics Holdings (EKSO) | United States | $0.020B | 0.00 |
NexGel (NXGL) | United States | $0.019B | 0.00 |
Inspira Technologies OXY B.H.N (IINN) | Israel | $0.017B | 0.00 |
Microbot Medical (MBOT) | United States | $0.017B | 0.00 |
Aspira Women's Health (AWH) | United States | $0.015B | 0.00 |
Autonomix Medical (AMIX) | United States | $0.014B | 0.00 |
QT Imaging Holdings (QTI) | United States | $0.014B | 0.00 |
PAVmed (PAVM) | United States | $0.011B | 0.00 |
Check-Cap (CHEK) | Israel | $0.009B | 0.00 |
ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
Venus Concept (VERO) | Canada | $0.003B | 0.00 |
ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
Nuwellis (NUWE) | United States | $0.003B | 0.00 |
SINTX TECHNOLOGIES, INC (SINT) | United States | $0.002B | 0.00 |
Avinger (AVGR) | United States | $0.002B | 0.00 |
Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
Tenon Medical (TNON) | United States | $0.002B | 0.00 |
Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |